ArticleEuropean journal of neurology2025

Reassessing BD-Tau as a Prognostic Biomarker in Guillain-Barré Syndrome: Methodological Considerations for Clinical Interpretation.

Umar AzizPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.